{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:39:14Z","timestamp":1792157954022,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology of Japan","doi-asserted-by":"crossref","award":["KAKENHI 17H06397, 19H03770"],"award-info":[{"award-number":["KAKENHI 17H06397, 19H03770"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21bm0804032h0001, JP22bm0804032h0002, JP23bm0804032h0003"],"award-info":[{"award-number":["JP21bm0804032h0001, JP22bm0804032h0002, JP23bm0804032h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Middle cerebral artery steno-occlusive disease (MCAD) has been recognized as a different clinical entity from moyamoya disease (MMD). Although MCAD can progress to MMD, the extent to which patients actually progress and the risk factors for this progression have not been fully elucidated. We retrospectively reviewed patients with MCAD who underwent\n                    <jats:italic>RNF213<\/jats:italic>\n                    genotyping. Demographic features,\n                    <jats:italic>RNF213<\/jats:italic>\n                    p.R4810K mutation, medical history, and longitudinal changes in angiography were analyzed. Sixty patients with 81 affected hemispheres were enrolled. During the follow-up period, 17 patients developed MMD, and the\n                    <jats:italic>RNF213<\/jats:italic>\n                    p.R4810K mutation was the only factor significantly associated with progression to MMD (odds ratio, 16.1; 95% CI, 2.13\u2013731;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.001). The log-rank test demonstrated that patients with the mutation had a higher risk of progression to MMD (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.007), stenosis progression (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.010), and symptomatic cerebral infarction or hemorrhage (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.026). In Cox regression analysis the p.R4810K mutation remained a significant factor after adjusting for age group (childhood or adult onset) at diagnosis (hazard ratio, 8.42; 95% CI, 1.10\u201364.4). Hemisphere-based analysis also showed that the mutation was associated with a higher risk of progression to the MMD hemisphere (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.002), stenosis progression (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.005), and cerebral infarction or hemorrhage (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.012). The\n                    <jats:italic>RNF213<\/jats:italic>\n                    p.R4810K mutation was identified as a risk factor for progression from MCAD to MMD. Genotyping for this mutation may contribute to risk stratification in MCAD.\n                  <\/jats:p>","DOI":"10.1007\/s12975-024-01293-2","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T18:02:06Z","timestamp":1724781726000},"page":"1146-1155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["RNF213 Mutation Associated with the Progression from Middle Cerebral Artery Steno-Occlusive Disease to Moyamoya Disease"],"prefix":"10.1007","volume":"16","author":[{"given":"Tomoki","family":"Sasagasako","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Mineharu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Funaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Chihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silsu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuzumi","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Okawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"1293_CR1","first-page":"135","volume":"18","author":"Y Korogi","year":"1997","unstructured":"Korogi Y, Takahashi M, Nakagawa T, Mabuchi N, Watabe T, Shiokawa Y, et al. Intracranial vascular stenosis and occlusion: MR angiographic findings. Am J Neuroradiol. 1997;18:135\u201343.","journal-title":"Am J Neuroradiol"},{"key":"1293_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3174\/ajnr.A4069","volume":"36","author":"G Telman","year":"2015","unstructured":"Telman G, Hurani H, Sprecher E, Kouperberg E. Middle cerebral artery stenosis in patients with acute ischemic stroke and TIA in Israel. Am J Neuroradiol. 2015;36:46\u20139.","journal-title":"Am J Neuroradiol"},{"key":"1293_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2176\/nmc.52.339","volume":"52","author":"Y Shimoda","year":"2012","unstructured":"Shimoda Y, Fujimura M, Inoue T, Shimizu H, Tominaga T. Temporal profile of de novo development of moyamoya vasculopathy in an adult. Neurol Med Chir (Tokyo). 2012;52:339\u201342.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"1293_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1212\/01.wnl.0000244412.18039.03","volume":"68","author":"HY Choi","year":"2007","unstructured":"Choi HY, Lee JE, Jung YH, Cho HJ, Kim DJ, Heo JH. Progression of isolated middle cerebral artery stenosis into moyamoya disease. Neurology. 2007;68:954.","journal-title":"Neurology"},{"key":"1293_CR5","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.04.019","volume":"26","author":"Y Matsuda","year":"2017","unstructured":"Matsuda Y, Mineharu Y, Kimura M, Takagi Y, Kobayashi H, Hitomi T, et al. RNF213 p. R4810K Variant and intracranial arterial stenosis or ccclusion in relatives of patients with moyamoya disease. J Stroke Cerebrovasc Dis. 2017;26:1841\u20137. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.04.019.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1293_CR6","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/jnnp.2006.096040","volume":"77","author":"Y Mineharu","year":"2006","unstructured":"Mineharu Y, Takenaka K, Yamakawa H, Inoue K, Ikeda H, Kikuta KI, et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry. 2006;77:1025\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1293_CR7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s12975-019-00743-6","volume":"11","author":"OY Bang","year":"2020","unstructured":"Bang OY, Chung JW, Kim DH, Won HH, Yeon JY, Ki CS, et al. Moyamoya disease and spectrums of RNF213 vasculopathy. Transl Stroke Res. 2020;11:580\u20139.","journal-title":"Transl Stroke Res"},{"key":"1293_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"JTA Suzuki","year":"1969","unstructured":"Suzuki JTA. Cerebrovascular \u201cmoyamoya\u201d disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288\u201399.","journal-title":"Arch Neurol"},{"key":"1293_CR9","doi-asserted-by":"publisher","first-page":"824","DOI":"10.2176\/nmc.50.824","volume":"50","author":"JC Takahashi","year":"2010","unstructured":"Takahashi JC, Miyamoto S. Moyamoya disease: recent progress and outlook. Neurol Med Chir (Tokyo). 2010;50:824\u201332.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"1293_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011;56:34\u201340.","journal-title":"J Hum Genet"},{"key":"1293_CR11","doi-asserted-by":"publisher","first-page":"e22542","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"W Liu","year":"2011","unstructured":"Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011;6:e22542.","journal-title":"PLoS One"},{"key":"1293_CR12","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.07.004","volume":"25","author":"T Morimoto","year":"2016","unstructured":"Morimoto T, Mineharu Y, Kobayashi H, Harada KH, Funaki T, Takagi Y, et al. Significant association of the RNF213 p. R4810K polymorphism with quasi-moyamoya disease. J Stroke Cerebrovasc Dis. 2016;25:2632\u20136. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2016.07.004.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1293_CR13","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1161\/STROKEAHA.122.041932","volume":"54","author":"S Kuroda","year":"2023","unstructured":"Kuroda S, Yamamoto S, Funaki T, Fujimura M, Kataoka H, Hishikawa T, et al. Five-year stroke risk and its predictors in asymptomatic moyamoya disease: asymptomatic moyamoya registry (AMORE). Stroke. 2023;54:1494\u2013504.","journal-title":"Stroke"},{"key":"1293_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2176\/jns-nmc.2021-0382","volume":"62","author":"M Fujimura","year":"2022","unstructured":"Fujimura M, Tominaga T, Kuroda S, Takahashi JC, Endo H, Ogasawara K, et al. 2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society. Neurol Med Chir (Tokyo). 2022;62:165\u201370.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"1293_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3171\/jns.1981.54.2.0151","volume":"54","author":"H Gibo","year":"1981","unstructured":"Gibo H, Carver CC, Rhoton AL Jr, Lenkey CMR. Microsurgical anatomy of the middle cerebral artery. J Neurosurg. 1981;54:151\u201369.","journal-title":"J Neurosurg"},{"key":"1293_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2176\/jns-nmc.2022-0072","volume":"62","author":"S Kuroda","year":"2022","unstructured":"Kuroda S, Fujimura M, Takahashi J, Kataoka H, Ogasawara K, Iwama T, et al. Diagnostic criteria for moyamoya disease-2021 revised version. Neurol Med Chir. 2022;62:307\u201312.","journal-title":"Neurol Med Chir"},{"key":"1293_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Medica. 2012;22:276\u201382.","journal-title":"Biochem Medica"},{"key":"1293_CR18","first-page":"643","volume":"21","author":"OB Samuels","year":"2000","unstructured":"Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI. A standardized method for measuring intracranial arterial stenosis. Am J Neuroradiol. 2000;21:643\u20136.","journal-title":"Am J Neuroradiol"},{"key":"1293_CR19","first-page":"2340","volume":"27","author":"P Lavados","year":"1996","unstructured":"Lavados P, Oppenheimer S, Enger C, Wong KS, Lam WWM. Variability of magnetic resonance angiography and computed tomography angiography in grading middle cerebral artery stenosis using the unweighted kappa statistic [4]. Stroke. 1996;27:2340.","journal-title":"Stroke"},{"key":"1293_CR20","doi-asserted-by":"publisher","first-page":"e200029","DOI":"10.1212\/NXG.0000000000200029","volume":"8","author":"S Okazaki","year":"2022","unstructured":"Okazaki S, Yoshimoto T, Ohara M, Takagaki M, Nakamura H, Watanabe K, et al. Effect of the RNF213 p.R4810K variant on the progression of intracranial artery stenosis. Neurol Genet. 2022;8:e200029.","journal-title":"Neurol Genet"},{"key":"1293_CR21","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.3171\/2015.6.JNS15845","volume":"124","author":"AT Funaki","year":"2016","unstructured":"Funaki AT, Takahashi JC, Yoshida K, Takagi Y, Fushimi Y, Kikuchi T, et al. Periventricular anastomosis in moyamoya disease: detecting fragile collateral vessels with MR angiography. J Neurosurg. 2016;124:1766\u201372.","journal-title":"J Neurosurg"},{"key":"1293_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2176\/nmc.oa.2014-0360","volume":"55","author":"T Funaki","year":"2015","unstructured":"Funaki T, Fushimi Y, Takahashi JC, Takagi Y, Araki Y, Yoshida K, et al. Visualization of periventricular collaterals in moyamoya disease with flow-sensitive black-blood magnetic resonance angiography: preliminary experience. Neurol Med Chir. 2015;55:204\u20139.","journal-title":"Neurol Med Chir"},{"key":"1293_CR23","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3174\/ajnr.A7609","volume":"43","author":"T Funaki","year":"2022","unstructured":"Funaki T, Miyakoshi A, Kataoka H, Takahashi JC, Takagi Y, Yoshida K, et al. Larger posterior revascularization associated with reduction of choroidal anastomosis in moyamoya disease: a quantitative angiographic analysis. Am J Neuroradiol. 2022;43:1279\u201385.","journal-title":"Am J Neuroradiol"},{"key":"1293_CR24","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.3171\/2020.9.JNS202709","volume":"135","author":"F Connolly","year":"2021","unstructured":"Connolly F, Alsolivany J, Czabanka M, Vajkoczy P, Valdueza JM, R\u00f6hl JE, et al. Blood volume flow in the superficial temporal artery assessed by duplex sonography: predicting extracranial-intracranial bypass patency in moyamoya disease. J Neurosurg. 2021;135:1666\u201373.","journal-title":"J Neurosurg"},{"key":"1293_CR25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.wneu.2019.04.066","volume":"127","author":"T Sasagasako","year":"2019","unstructured":"Sasagasako T, Funaki T, Tanji M, Arakawa Y, Suzuki H, Miyakoshi A, et al. Intractable medial anastomotic branches from the lenticulostriate artery causing recurrent hemorrhages in moyamoya disease. World Neurosurg. 2019;127:279\u201383. https:\/\/doi.org\/10.1016\/j.wneu.2019.04.066.","journal-title":"World Neurosurg"},{"key":"1293_CR26","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2176\/nmc.tn.2019-0162","volume":"59","author":"T Funaki","year":"2019","unstructured":"Funaki T, Kataoka H, Yoshida K, Kikuchi T, Mineharu Y, Okawa M, et al. The targeted bypass strategy for preventing hemorrhage in moyamoya disease: technical note. Neurol Med Chir. 2019;59:517\u201322.","journal-title":"Neurol Med Chir"},{"key":"1293_CR27","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"1293_CR28","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3171\/2021.3.JNS203913","volume":"136","author":"Y Mineharu","year":"2022","unstructured":"Mineharu Y, Takagi Y, Koizumi A, Morimoto T, Funaki T, Hishikawa T, et al. Genetic and nongenetic factors for contralateral progression of unilateral moyamoya disease: the first report from the SUPRA Japan Study Group. J Neurosurg. 2022;136:1005\u201314.","journal-title":"J Neurosurg"},{"issue":"15","key":"1293_CR29","doi-asserted-by":"publisher","first-page":"e025676","DOI":"10.1161\/JAHA.122.025676","volume":"11","author":"T Ok","year":"2022","unstructured":"Ok T, Jung YH, Kim J, Park SK, Park G, Lee S, et al. RNF213 R4810K variant in suspected unilateral moyamoya disease predicts contralateral progression. J Am Heart Assoc. 2022;11(15):e025676.","journal-title":"J Am Heart Assoc"},{"key":"1293_CR30","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.molmed.2022.08.009","volume":"28","author":"C Asselman","year":"2022","unstructured":"Asselman C, Hemelsoet D, Eggermont D, Dermaut B, Impens F. Moyamoya disease emerging as an immune-related angiopathy. Trends Mol Med. 2022;28:939\u201350. https:\/\/doi.org\/10.1016\/j.molmed.2022.08.009.","journal-title":"Trends Mol Med"},{"key":"1293_CR31","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1161\/STROKEAHA.116.012751","volume":"47","author":"YJ Kim","year":"2016","unstructured":"Kim YJ, Lee JK, Ahn SH, Kim BJ, Kang DW, Kim JS, et al. Nonatheroscleotic isolated middle cerebral artery disease may be early manifestation of moyamoya disease. Stroke. 2016;47:2229\u201335.","journal-title":"Stroke"},{"key":"1293_CR32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.5853\/jos.2018.00150","volume":"20","author":"OY Bang","year":"2018","unstructured":"Bang OY, Toyoda K, Arenillas JF, Liu L, Kim JS. Intracranial large artery disease of non-atherosclerotic origin: recent progress and clinical implications. J Stroke. 2018;20:208\u201317.","journal-title":"J Stroke"},{"key":"1293_CR33","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1161\/STROKEAHA.118.024712","volume":"50","author":"T Kamimura","year":"2019","unstructured":"Kamimura T, Okazaki S, Morimoto T, Kobayashi H, Harada K, Tomita T, et al. Prevalence of RNF213 p. R4810K variant in early-onset stroke with intracranial arterial stenosis. Stroke. 2019;50:1561\u20133.","journal-title":"Stroke"},{"key":"1293_CR34","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s12975-021-00956-8","volume":"13","author":"D Ishigami","year":"2022","unstructured":"Ishigami D, Miyawaki S, Imai H, Shimizu M, Hongo H, Dofuku S, et al. RNF213 p.Arg4810Lys heterozygosity in moyamoya disease indicates early onset and bilateral cerebrovascular events. Transl Stroke Res. 2022;13:410\u20139.","journal-title":"Transl Stroke Res"},{"key":"1293_CR35","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3171\/2018.10.JNS181139","volume":"132","author":"T Funaki","year":"2020","unstructured":"Funaki T, Takahashi JC, Houkin K, Kuroda S, Fujimura M, Tomata Y, et al. Effect of choroidal collateral vessels on de novo hemorrhage in moyamoya disease: analysis of nonhemorrhagic hemispheres in the Japan Adult Moyamoya Trial. J Neurosurg. 2020;132:408\u201314.","journal-title":"J Neurosurg"},{"key":"1293_CR36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3171\/2017.9.JNS17576","volume":"130","author":"T Funaki","year":"2019","unstructured":"Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, et al. High rebleeding risk associated with choroidal collateral vessels in hemorrhagic moyamoya disease: analysis of a nonsurgical cohort in the Japan Adult Moyamoya Trial. J Neurosurg. 2019;130:525\u201330.","journal-title":"J Neurosurg"},{"key":"1293_CR37","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3171\/2016.11.JNS161650","volume":"128","author":"T Funaki","year":"2018","unstructured":"Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, et al. Angiographic features of hemorrhagic moyamoya disease with high recurrence risk: a supplementary analysis of the Japan Adult Moyamoya Trial. J Neurosurg. 2018;128:777\u201384.","journal-title":"J Neurosurg"},{"key":"1293_CR38","first-page":"1674","volume":"40","author":"A Miyakoshi","year":"2019","unstructured":"Miyakoshi A, Funaki T, Fushimi Y, Kikuchi T, Kataoka H, Yoshida K, et al. Identification of the bleeding point in hemorrhagic moyamoya disease using fusion images of susceptibility-weighted imaging and time-of-flight MRA. Am J Neuroradiol. 2019;40:1674\u201380.","journal-title":"Am J Neuroradiol"},{"key":"1293_CR39","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1161\/STROKEAHA.121.038066","volume":"53","author":"Y Xue","year":"2022","unstructured":"Xue Y, Zeng C, Ge P, Liu C, Li J, Zhang Y, et al. Association of RNF213 variants with periventricular anastomosis in moyamoya disease. Stroke. 2022;53:2906\u201316.","journal-title":"Stroke"},{"key":"1293_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12199-015-0498-7","volume":"21","author":"A Koizumi","year":"2016","unstructured":"Koizumi A, Kobayashi H, Hitomi T, Harada KH, Habu T, Youssefian S. A new horizon of moyamoya disease and associated health risks explored through RNF213. Environ Health Prev Med. 2016;21:55\u201370.","journal-title":"Environ Health Prev Med"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-024-01293-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-024-01293-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-024-01293-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T02:46:07Z","timestamp":1750905967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-024-01293-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1293"],"URL":"https:\/\/doi.org\/10.1007\/s12975-024-01293-2","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Kyoto University Hospital (G1109 and R2088). All participants or their guardians provided written informed consent (and assent if possible) after receiving a detailed explanation of the study. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}